Anti-inflammatory gene therapy directed at the airway epithelium

Gene Therapy

Volumn 7, Issue 4, 2000, Pages 306-313

  Griesenbach, U ^a,c   Scheid, P ^a   Hillery, E ^a   De Martin, R ^b   Huang, L ^d   Geddes, D M ^a   Alton, E W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d NONE

Author keywords

Gene therapy; Inflammation; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOSOME; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANIMALIA;

EID: 0033997932     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301078     Document Type: Article

References (42)

1. Burnett D. Neutrophils. In: Stockely RA (ed). Pulmonary Defenses. John Wiley: New York, 1997, pp 113-127.
2. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Resp Dis 1990; 141: 471-501.
3. Nadel JA. Protease actions on airway secretions. Relevance to cystic fibrosis. Ann NY Acad Sci 1991; 624: 286-296.
4. Dean TP et al. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993; 34: 159-161.
5. DiMango E, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995; 96: 2204-2210.
6. Scheid P et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence (submitted for publication).
7. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Ann Rev Immunol 1994; 12: 141-179.
8. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997; 336: 1066-1071.
9. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1-62.
10. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J 1991; 10: 3805-3817.
11. Whiteside ST, Epinat JC, Rice NR, Israel A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 1997; 16: 1413-1426.
12. Brown K et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995; 267: 1485-1488.
13. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 1994; 13: 5433-5441.
14. Kunsch C, Rosen CA. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Molec Cell Biol 1993; 13: 6137-6146.
15. DiMango E et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invent 1998; 101: 2598-2605.
16. Li JD et al. Activation of NF-kappaB via a Src-dependent RasMAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Prof Natl Acad Sci USA 1998; 95: 5718-5723.
17. Hart LA et al. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Resp Crit Care Med 1998; 158: 1585-1592.
18. Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 1998; 38: 981-993.
19. Tomita N et al. Transcription factor decoy for nuclear factor-kappa B inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J Hypertens 1998; 16: 993-1000.
20. Makarov SS et al. NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Therapy 1997; 4: 846-852.
21. Wrighton CJ et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med 1996; 183: 1013-1022.
22. Morishita R et al. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nature Med 1997; 3: 894-899.
23. Bohrer H et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 1997; 100: 972-985.
24. Blackwell TS et al. In vivo antioxidant treatment suppresses nuclear factor kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157: 1630-1637.
25. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Resp Cell Mol Biol 1993; 8: 20-27.
26. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allerg Clin Immunol 1992; 89: 1001-1009.
27. Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
28. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
29. Kitson C et al. The extra-and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Therapy 1999; 6: 534-546.
30. Sorgi FL, Bhattacharya S, Huang L. Proteamine sulfate enhances lipid-mediated gene transfer. Gene Therapy 1997; 4: 961-968.
31. Zelphati O, Liang XW, Hobart P, Feigner PL. Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. Hum Gene Ther 1999; 10: 15-24.
32. Leonetti JP et al. Intracellular distribution of microinjected antisense oligonucleotides. Proc Nntl Acad Sci USA 1991; 88: 2702-2706.
33. Chin DJ et al. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol 1990; 2: 1091-1100.
34. Dean DA. Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res 1997; 230: 293-302.
35. Kaplan JM et al. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther 1998; 9: 1469-1479.
36. Graham FL, Van der Eb AJ. A simple technique for the assay of irfectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
37. Traenckner EB et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995; 142: 2876-2883.
38. Sorgi FL, Huang L. Large scale production of DC-Chol cationic liposomes by microfluidization. Int J Pharm 1996; 144: 131-139.
39. Pahl HL, Baeuerle PA. A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NFkB. EMBO J 1995; 14: 2580-2588.
40. Peterson GL. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem 1977; 83: 346-356.
41. Davies JC et al. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Resp Cell Mol Biol 1997; 16: 657-663.
42. Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996; 7: 1701-1717.